RecruitingNCT06986980

Intestinal Microsporidiosis in French Heart Transplant Recipients (CARMIC)

Intestinal Microsporidiosis in French Heart Transplant Recipients


Sponsor

University Hospital, Clermont-Ferrand

Enrollment

39 participants

Start Date

May 5, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The investigators propose to carry out a national retrospective study to collect epidemiological, biological, clinical and therapeutic data on microsporidiosis among heart transplant patients.


Eligibility

Inclusion Criteria2

  • heart transplant patients diagnosed with intestinal microsporidiosis
  • diagnosis made before December 31, 2024 in France (metropolitan France and overseas territories)

Exclusion Criteria1

  • patient opposition

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

CHU Gabriel Montpied

Clermont-Ferrand, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06986980


Related Trials